Technical Analysis for ICOTF - Ico Therapeutics

Grade Last Price % Change Price Change
grade B 0.0614 -0.97% -0.0006
ICOTF closed down 0.97 percent on Friday, August 23, 2019, on 10 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical ICOTF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -0.97%
Inside Day Range Contraction -0.97%
Wide Bands Range Expansion -0.97%
Crossed Above 200 DMA Bullish -16.91%
Crossed Above 20 DMA Bullish -16.91%
Crossed Above 50 DMA Bullish -16.91%
MACD Bullish Signal Line Cross Bullish -16.91%

Older signals for ICOTF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
iCo Therapeutics Inc. (iCo) is a Canada-based biotechnology company principally focused on the identification, development and commercialization of drug candidates to treat sight-and life-threatening diseases. The Company principally focuses on in-licensing drug candidates with a clinical history, and re-dose, reformulate and develop drug candidates for the treatment of sight-and life-threatening diseases. The Company's product candidates include iCo-007, iCo-008 and an Oral AmpB Delivery System. The Company has initiated Phase II clinical trial for iCo-007. iCo-008 is a human monoclonal antibody that is offered to treat sight threatening forms of allergic conjunctivitis by neutralizing eotaxin-1, a ligand to the chemokine receptor CCR3. Oral AmpB Delivery System is a toxic option for the treatment of serious systemic fungal infections. The Company has completed pre-clinical studies for iCo's Oral AmpB Delivery System.
Health Biotechnology Branches Of Biology Clinical Trial Allergic Conjunctivitis Cytokines Bertilimumab
Is ICOTF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.2035
52 Week Low 0.02
Average Volume 10,532
200-Day Moving Average 0.0601
50-Day Moving Average 0.0547
20-Day Moving Average 0.0514
10-Day Moving Average 0.0503
Average True Range 0.0073
ADX 12.57
+DI 52.9931
-DI 29.735
Chandelier Exit (Long, 3 ATRs ) 0.05199999999999999
Chandelier Exit (Short, 3 ATRs ) 0.0629
Upper Bollinger Band 0.0719
Lower Bollinger Band 0.0309
Percent B (%b) 0.74
BandWidth 79.766537
MACD Line -0.0003
MACD Signal Line -0.0025
MACD Histogram 0.0022
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0614
Resistance 3 (R3) 0.0614 0.0614 0.0614
Resistance 2 (R2) 0.0614 0.0614 0.0614 0.0614
Resistance 1 (R1) 0.0614 0.0614 0.0614 0.0614 0.0614
Pivot Point 0.0614 0.0614 0.0614 0.0614 0.0614
Support 1 (S1) 0.0614 0.0614 0.0614 0.0614 0.0614
Support 2 (S2) 0.0614 0.0614 0.0614 0.0614
Support 3 (S3) 0.0614 0.0614 0.0614
Support 4 (S4) 0.0614